OBX Obsidian Therapeutics, Inc. - Common Stock
$19.92
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026
52W Range
$15–$50
15% of range
Analyst Rating
—
Price Target
$42
+111% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—
OBX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$19.92
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$15 – $50
OBX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
—
Free Cash Flow
—
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
OBX
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
OBX
Peer Median
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
OBX
Peer Median
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
OBX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
OBX
Peer Median
OBX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
1 analysts · 2026-08-18
Low
$42.00
High
$42.00
Median target
$42.00
+110.8%
Mean target
$42.00
+110.8%
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 1
| Metric | Trend | Q2 2026 |
|---|---|---|
| Net Income | $0 |
Balance Sheet 11
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Assets | $0 | |
| Other Non-current Assets | $0 | |
| Total Assets | $0 | |
| Current Liabilities | $0 | |
| Other Non-current Liabilities | $0 | |
| Common Stock | $0 | |
| Retained Earnings | $0 | |
| AOCI | $0 | |
| Stockholders' Equity | $0 | |
| Liabilities + Equity | $0 | |
| Shares Outstanding | 1,000 |
Cash Flow 4
| Metric | Trend | Q2 2026 |
|---|---|---|
| Operating Cash Flow | $0 | |
| Investing Cash Flow | $0 | |
| Financing Cash Flow | $0 | |
| Net Change in Cash | $0 |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Company insiders 5 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Madan Jagasia | — | Aug. 3, 2026 A | — | 0 | 0 | $0 |
| Matthew Norkunas | — | Aug. 3, 2026 A | — | 0 | 0 | $0 |
| Robert W. Ross | — | Aug. 3, 2026 A | — | 0 | 0 | $0 |
| Heidi Hagen | — | Aug. 3, 2026 A | — | 0 | 0 | $0 |
| Maria Fardis | — | Aug. 3, 2026 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 4 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VRIG · Invesco Actively Managed Exchange-T… | — | — | Aug. 18, 2026 | Daily |
| GSY · Invesco Actively Managed Exchange-T… | — | — | Aug. 11, 2026 | Daily |
| GTO · Invesco Actively Managed Exchange-T… | — | — | Aug. 18, 2026 | Daily |
| GTOS · Invesco Actively Managed Exchange-T… | — | — | Aug. 14, 2026 | Daily |